FEATURES AND TREATMENT OF BACTERIAL VAGINOSIS IN WOMEN

Bacterial vaginosis: clinical, epidemiologic and microbiological features

Bacterial Vaginosis (BV) is a polymicrobial clinical syndrome, whose etiology has not been fully understood. It occurs in approximately 30% of the women in childbearing age and is the result of the shift of protective resident microorganisms as Lactobacillus spp. by opportunistic pathogenic bacteria such as Gardnerella vaginalis. Patients with BV generally present copious, thin, homogeneous, mi...

Local treatment for bacterial vaginosis.

Bacterial vaginosis (non-specific vaginitis) is a mild but common condition. O'Dowd et al reported that organisms associated with vaginosis could be isolated from 37% of women who presented with vaginal symptoms. The current treatment of choice is an oral nitroimidazole (metronidazole or tinidazole), given either as a single large dose or as a twice daily regimen for five to seven days. A probl...

Tinidazole in the treatment of bacterial vaginosis

Bacterial vaginosis (BV) is the commonest cause of vaginal discharge in women of childbearing age. Oral metronidazole has long been established as an effective therapy in the treatment of BV. However, adverse effects due to metronidazole are frequent and this may lead to problems with adherence to a 7-day course of treatment and subsequently result in treatment failure. Oral tinidazole has been...

Bacterial Vaginosis: Update on Pathogenesis and Treatment

etiology, significance, diagnosis and treatment of bruxiam

چکیده ندارد.